EOL
Energy One Limited
🇦🇺 ASX
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 39.60%
Annual Growth
5 years average annual growth
💰
1.23%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Energy One Ltd. engages in the business of supplying and developing software and services to energy companies and utilities. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2007-01-15. The Company’s principal activity is the development and supply of software and services as well as energy trading and associated advisory services to energy companies and utilities. The Company’s segments include Energy Software and Energy Trading Industry. Its geographical segments include Australasia, CQ Energy and the United Kingdom /Europe. The Company’s software and services include advisory services, demand-linked risk management solutions, egssPort, EnergyOffer, enFlow, enPrice, enTrader, enVoy, EOT, eZ-Ops, generation services, NemSight, managed services, pypIT, SimEnergy, plant outage insurance, weather-linked risk management solutions, and global 24/7 outsourced operations services. The company serves a range of customers across the globe, including energy retailers, generators, users, customers.
📈 Performance
Price History
+1592.44%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
1.23%
💰 Annual Dividend Earnings Per $1,000 invested**
$12.32
💰 Most Recent Dividend Franked Percentage Estimate
0.00%
💰 Average Dividend Franked Percentage Estimate
0.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of EOL, your last dividend payment(s) would have been:
$ 117.88
on Thu Oct 20 2022
$ 111.55
on Mon Oct 18 2021
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.06
NaN%
2020
$0.04
NaN%
2019
$0.03
NaN%
2018
$0.02
NaN%
2017
$0.01
NaN%
2016
$0.01
0.00%
2015
$0.00
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$6.84
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EOL
7
📊 Total Capital Earnings
$12K
🔃 Average investment frequency
20 weeks
💵 Average investment amount
$877
⏰ Last time a customer invested in EOL
147 days
EOL investor breakdown
💵 Income of investors
More than 200k
8%
150k - 200k
31%
100k - 150k
8%
50k - 100k
23%
Less than 50k
31%
👶 Age of investors
18 - 25
14%
26 - 34
29%
35 - 90
57%
🙋 Legal gender of investors
Female
29%
Male
71%
Pearlers who invest in EOL also invest in...
RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 9,980 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. The Company’s segments include Sleep and Respiratory Care and SaaS. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care to improve patient outcomes.
🙌 Performance (5Yr p.a)
12.46%
📊 Share price
$36.50 AUD
📈 HIGH PRICE GROWTH
🌳 ENVIRONMENTAL
🕊️ SOCIALLY AWARE
🩺 HEALTH CARE
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.
🙌 Performance (5Yr p.a)
-0.04%
📊 Share price
$278.11 AUD
🧬 BIOTECHNOLOGY
🕊️ SOCIALLY AWARE
NDQ
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
27.66%
📊 Share price
$50.95 AUD
🇺🇸 UNITED STATES
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.56%
📊 Share price
$63.57 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Want more shares? Try these...
Electro Optic Systems Holdings Ltd. develops and produces products incorporating advanced electro-optic technologies for the aerospace market. The company operates in two divisions: Defence Systems and Space Systems. The Defence Systems division specializes in technology for weapon systems optimization and integration, as well as ISR (Intelligence, Surveillance and Reconnaissance) and C4 systems for land warfare. Its key products include remote weapon systems, vehicle turrets, high-energy laser weapons (directed energy), as well as fully integrated and modular counter-UAS and C4 systems. The Space Systems division includes all EOS space and communications businesses, and operates as two entities, Space Technologies, and EM Solutions. Space Technologies specializes in applying EOS-developed optical sensors and effectors to detect, track and characterize objects in space. EM Solutions delivers radio frequency (RF) and optical space communications technology.
🙌 Performance (5Yr p.a)
-16.73%
📊 Share price
$1.18 AUD
🚀 AEROSPACE & DEFENSE
E&P Financial Group Ltd. engages in the provision of financial services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-05-14. The Company’s segments include E&P Wealth, E&P Capital and E&P Funds. E&P Wealth segment relates to the provision of full-service investment advisory, financial strategy, portfolio administration and stockbroking services. E&P Capital segment relates to the provision of stockbroking and investment advisory services to institutional clients and advice to corporations on mergers, acquisitions, and equity and debt capital market transactions. E&P Funds segment relates to the provision of investment management services, fund accounting and administration services, Responsible Entity services to managed investment schemes and provision of ancillary services to client fund operations, including construction, project management, design and architectural services and other real estate services. The firm operates across Sydney, Melbourne, Canberra, Brisbane, New Jersey and Hong Kong.
🙌 Performance (5Yr p.a)
-8.68%
📊 Share price
$0.52 AUD
💸 FINANCIALS
Enegex Ltd. engages in the exploration, evaluation, and investment of natural resources. The principal activity of the Company includes natural resources exploration, evaluation and investment. The firm's West Yilgarn projects cover approximately 2,942 square kilometers (km2), all within 200 kilometers (km). Its West Yilgarn tenements is divided into five project areas: Perenjori, Miamoon, Walebing, Goomalling and Green Hills. The Perenjori Project is situated to the north of Miamoon and covers several northwest trending aeromagnetic and gravity corridors thought to be the continuation of the gneiss and partially preserved greenstone terrain in the Miamoon and eastern Walebing areas. The Miamoon project comprises five exploration licenses (E70/5446, E70/5457, E70/5458, E70/5460 and E70/5463). The Walebing project includes five exploration licenses (E70/5439, E70/5440, E70/5441, E70/5442 and E70/5631).
🙌 Performance (5Yr p.a)
15.14%
📊 Share price
$0.01 AUD
⛏️ MINING
📈 HIGH PRICE GROWTH
Ecofibre Ltd. engages in the research, production, and sale of polymer-based industrial products, and hemp derived nutraceuticals and food. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-03-29. The company also owns interest in a life sciences business that is developing treatments for malignant and non-malignant gynecological diseases. Its segments include Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, Ecofibre Corporate, and EOF Bio Inc. Ecofibre Advanced Technologies segment is engaged in advanced manufacturing business in performance yarn extrusion, polymer compounding and textiles manufactured in the United States. Ananda Health segment is engaged in the production and sale of hemp related and other nutraceutical products in the United States and Australia. Ecofibre Genetics segment is engaged in the supply of seed genetics to the hemp fiber and grain industry in the United States and Australia. Ecofibre Corporate segment is engaged in group corporate and shared service functions.
🙌 Performance (5Yr p.a)
-19.74%
📊 Share price
$0.03 AUD
📦 LOGISTICS